Short description
Helix Therapeutics developed DNA-based therapeutics for the treatment of HIV/AIDS and common genetic diseases.
Description
Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
New Haven, Connecticut, United States, North America
Founded on
January 1, 2006
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
No Way, Noway Youcantaccess, Noaccess
Sign in for full access
Founders
Peter M. Glazer, Ranjit S. Bindra